Biotech Values

[apljack]

SPPI/Zevalin:

This is a sample size of one, but every little bit helps (SPPI that is).

http://www.ncbi.nlm.nih.gov/pubmed/22820440

Second-Line 90Yttrium-Ibritumomab Tiuxetan (Zevalin) in a Patient With Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma Refractory to Rituximab.

Oellers P, Savar A, Samaniego F, Pro B, Esmaeli B.

*Section of Ophthalmology, Department of Head and Neck Surgery; and †Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, U.S.A.

Abstract

Lymphoma of mucosa-associated lymphoid tissue (MALT) is the most common variety of lymphoma seen in the ocular adnexae. The authors present the case of a patient with MALT lymphoma refractory to treatment with rituximab. Subsequent treatment with 90Yttrium-Ibritumomab tiuxetan yielded a complete response.